Active Ca2+ reabsorption in the connecting tubule
The kidney plays a crucial role in the maintenance of the body calcium (Ca2+) balance. Ca2+ is an essential ion in all organisms and participates in a large variety of structural and functional processes. In mammals, active tubular Ca2+ reabsorption is restricted to the distal part of the nephron, i.e., the late distal convoluted (DCT2) and the connecting tubules (CNT), where approximately 10–15% of the total Ca2+ is reabsorbed. This active transcellular transport is hallmarked by the transient receptor potential vanilloid 5 (TRPV5) epithelial Ca2+ channel, regulated by an array of events, and mediated by hormones, including 1,25-dihydroxyvitamin D3, parathyroid hormone, and estrogen. Novel molecular mechanisms have been identified, such as the direct regulatory effects of klotho and tissue kallikrein on the abundance of TRPV5 at the apical membrane. The newly discovered mechanisms could provide potential pharmacological targets in the therapy of renal Ca2+ wasting. This review discusses the three basic molecular steps of active Ca2+ reabsorption in the DCT/CNT segments of the nephron, including apical entry, cytoplasmic transport, and basolateral extrusion of Ca2+. In addition, an overview of the recently identified mechanisms governing this active Ca2+ transport through the DCT2/CNT epithelial cells will be presented.
KeywordsTransepithelial Ca2+ transport TRPV5 PTH Vitamin D Klotho Calbindin
Regulation of Ca2+ transporters
Gene expression ↑
Gene expression ↑
Gene expression ↑,=
Gene expression ↑
Gene expression ↑
Gene expression ↑
Gene expression ↓
Gene expression ↓
Gene expression ↑
Plasma membrane abundance ↑
Gene expression ↑
Gene expression ↑
Transporter trafficking regulators
Plasma membrane abundance ↑
Plasma membrane abundance ↑
Plasma membrane abundance ↑
Plasma membrane abundance ↑
Transporter activity regulators
Plasma membrane retention ↑
Plasma membrane retention ↑
Plasma membrane retention ↑
Plasma membrane abundance ↑
Indirectly increased activity
Morphologic characteristics of the CNT
The above discussed distal segments of the nephron exhibit distinct morphological, as well as functional features. In the superficial cortex, the DCT/CNT region is short and flows directly into the cortical collecting duct (CCD). Midcortical and juxtamedullar nephrons, on the other hand, have longer DCT/CNTs merging with other CNT segments into arcades before transitioning to the CCD . DCTs consist of two short segments, DCT1 and DCT2, both comprising a uniform population of principal cells, whereas the CNT contains both principal and two types of intercalated cells [3, 16, 43, 56]. Furthermore, the principal cells in the CNT have less cell–cell contacts and mitochondria, and their apical membrane contains fewer projections than DCT cells. Unlike the polygonal-shaped CNT cells, intercalated cells appear to be round with an apical membrane densely adorned with microprojections [43, 56]. The proton secreting α-intercalated cells have extensive apical microvilli with abundant expression of the H+/K+ exchanger and vacuolar H+-ATPase and numerous subapically localized small mitochondria, whereas the bicarbonate secreting β-intercalated cells have fewer apical microvilli, and their mitochondria tend to accumulate basolaterally, where the proton pump is also located . Although the ratio of α- and β-intercalated cells vary depending on the actual physiological state, α-intercalated cells are more common in the CNT.
In addition to the ubiquitously expressed Na+/K+-ATPase, the Na+/Ca2+ exchanger (NCX1) and the plasma membrane ATPase type 1b (PMCA1b) have been found along the DCT2/CNT region, whereas the apically localized thiazide-sensitive Na+/Cl− co-transporter (NCC) and the transient receptor potential melastin subtype 6 are present in the DCT (see Xi et al. in this issue). The DCT2 region also shares additional similarities with the CNT segment, as both segments express the transient receptor potential vanilloid type 5 (TRPV5) and the Ca2+-binding protein calbindin-D28K. The tight junctions in these segments are impermeable for Ca2+, and transcellular Ca2+ transport occurs against an electrochemical gradient, supporting that Ca2+ reabsorption in the DCT2/CNT is mediated by active transepithelial transport.
Transepithelial Ca2+ reabsorption
TRPV5—the apical gate
TRPV5, also known as the epithelial Ca2+ channel, is a member of the TRP channel superfamily . This channel comprises large and flexible intracellular amino- and carboxyl-terminal tails flanking six transmembrane segments (TM) and an additional hydrophobic stretch between TM5 and TM6, predicted to be the pore-forming region. The amino-terminal tail contains six ankyrin repeats [19, 54] that are important structural elements for both channel assembly and protein–protein interactions [13, 19]. Furthermore, the first extracellular loop between TM1 and TM2 contains an evolutionary conserved asparagine (N358) crucial for complex-glycosylation and in turn for regulating channel activity [11, 13, 33]. The carboxyl-terminal tail harbors three potential protein kinase C (PKC) sites, which suggests an important role for phosphorylation in channel activity. Moreover, in cultured mammalian cell systems, as well as in oocytes, TRPV5 is assembled into large homotetramers in order to acquire the active conformation state [26, 33]. Facing each other, the hydrophobic stretches between TM5 and TM6 in each subunit are postulated to form the aqueous pore centered at the fourfold symmetry axis.
Detailed electrophysiological studies have compellingly demonstrated the constitutive activity of TRPV5 at low intracellular Ca2+ concentrations and physiological membrane potentials . The current–voltage relationship of TRPV5 shows strong inward rectification [29, 74, 75]. Another important functional feature of TRPV5 is the high Ca2+ selectivity, making this epithelial Ca2+ channel the most Ca2+-selective member in the TRP superfamily . Finally, the generation of a TRPV5 deficient mouse strain (TRPV5−/−) provided compelling evidence for the physiological function of this channel. Active Ca2+ reabsorption in DCT2 and CNT is severely impaired in these animals as TRPV5−/− mice waste approximately six- to tenfold more Ca2+ than their wild-type littermates, which is in line with the postulated gatekeeper function of TRPV5 in active Ca2+ reabsorption .
Shortly after the identification of TRPV5, a homologous channel, sharing 75% amino acid identity with TRPV5, was cloned from intestine and named TRPV6 . Although there are some functional differences between these channels, TRPV6 exhibits the same Ca2+ selectivity and current–voltage relationship [32, 47, 78]. Moreover, this latter channel has been implicated in intestinal Ca2+ absorption. Disturbances in the Ca2+ homeostasis were also reported in mice lacking TRPV6 (TRPV6−/−) as these animals display reduced intestinal Ca2+ absorption and low bone mineral density . Although it has been shown that TRPV6 is moderately expressed in adult kidney  and the TRPV6−/− mice have increased urinary Ca2+ excretion, the exact role of TRPV6 in the kidney is not yet fully understood.
Calbindin-D28K—the intracellular shuttle
The principal cells of the DCT2/CNT segments are continuously challenged by a substantial Ca2+ influx through TRPV5, yet the cells manage to maintain a low intracellular Ca2+ concentration ([Ca2+]i). Maintaining the free [Ca2+]i at the basal level is essential for several reasons. High levels of free Ca2+ in the cytoplasm are known to induce apoptosis and protein precipitation. In addition, Ca2+ has an essential signaling function for many processes in the cell. More importantly, an increased [Ca2+]i has been shown to inhibit the activity of TRPV5 . Based on the currently available data, three different models have been postulated for transepithelial Ca2+ transfer from the apical to the basolateral membrane. The first model is based on a passive diffusion tunneling through the endoplasmatic reticulum, vesicular transport along the microtubules involving lysosomes, and finally, facilitated diffusion. According to the second model, Ca2+-transporting cells utilize lysosomes to sequester Ca2+ and facilitate its movement to the basolateral membrane . The apical Ca2+ influx through TRPV5 initiates the disruption of the actin cytoskeleton and the formation of Ca2+-enriched endocytic vesicles, which are transported along the microtubules and some fuse with lysosomes . In a third model, the intracellular diffusion of Ca2+ is facilitated by the vitamin D3-dependent Ca2+-binding protein, calbindin-D28K, in the principal cells of DCT2 and CNT segments [7, 20]. Together with parvalbumin, calmodulin, and troponin C, calbindins are Ca2+-binding proteins that form a family of proteins with Ca2+ affinity . Calbindin-D28K has three pairs of EF-hands that are the structural basis of the high Ca2+ affinity binding capacity . Moreover, in the kidney, the expression of calbindin-D28K is restricted to DCT2, CNT, and CCD regions. It has also recently been shown that calbindin-D28K translocates to the TRPV5-containing plasma membranes upon a decrease in intracellular [Ca2+] and directly associates with this channel . Due to the relatively slow Ca2+-binding kinetics of calbindin-D28K, hormone-induced Ca2+ signaling can also occur independently of the transcellular Ca2+ transport rate . Bound to calbindin-D28K, Ca2+ is shuttled to the basolateral membrane, where Ca2+ is discharged into the blood flow by the basolateral Ca2+ extrusion systems. Finally, some studies reported that calbindin-D28K−/− mice fed a high Ca2+ diet have impaired renal Ca2+ handling as they excrete more Ca2+ in their urine than the wild-type control littermates , whereas other studies did not observe a difference that is probably due to the compensatory increase of renal calbindin-D9K expression . These data suggest that calbindin-D28K facilitates the intracellular diffusion of Ca2+ in DCT2 and CNT.
NCX1 and PMCA1b—the basolateral extrusion system
The energy-consuming step of transcellular Ca2+ transport lies in the Ca2+ efflux process. In this step, intracellular Ca2+ is transported across the basolateral membrane against its electrochemical gradient, and the ions are extruded back to the blood flow. Two transporters have been implicated in this mechanism, PMCA1b and NCX1. Plasma membrane ATPases are high-affinity Ca2+ efflux pumps that maintain the resting Ca2+ concentration in virtually all cells . The highest Ca2+-ATPase activity in kidney was reported in the DCT segment. However, earlier studies have suggested that the capacity of this PMCA pump in CNT seems to be insufficient to keep pace with the absorptive flux of Ca2+ because it can transport only ∼30% of the total Ca2+ efflux [2, 69]. In contrast to PMCA1b, the Na+/Ca2+ exchanger has been shown to be a prerequisite for transepithelial Ca2+ transport [2, 69]. NCX1 exchanges Ca2+ and Na+ generally in a 1:3 stoichiometric ratio. Moreover, NCX1 is a widely expressed protein as it can be found in several tissues, including the heart, brain, and skeletal muscle . In the kidney, the expression of NCX1 is restricted to the distal part of the nephron, particularly the CNT segment, where it predominantly localizes along the basolateral membrane [3, 28, 43] and accounts for the remaining 70% of the Ca2+ efflux [2, 69].
Regulatory mechanisms of Ca2+ transport in DCT2/CNT
The aforementioned transporters comprise the machinery transporting Ca2+ from pro-urine to the blood in the DCT2/CNT. Several factors have been shown to contribute to the regulation of the Ca2+ transporting capacity of these particular nephron segments, which can be classified into four categories: (1) the control of the overall abundance of the transporter proteins by calciotropic hormones, (2) the rate of intracellular trafficking of the plasma membrane transporters, (3) alteration of activity of the transport proteins in the membrane by intracellular factors, and finally, (4) tuning apical Ca2+ influx by extracellular (luminal) factors.
Controlling the abundance of Ca2+ transporters
Parathyroid hormone (PTH) is an essential component of the Ca2+ homeostasis. The secretion of PTH from the parathyroid gland is triggered by changes in blood Ca2+ levels sensed by the parathyroid Ca2+-sensing receptor . PTH receptors have been detected in DCT2/CNT, enabling the direct control of active Ca2+ reabsorption by PTH .
PTH-mediated regulation of the Ca2+ transporters was studied in parathyroidectomized rats . Parathyroidectomy reduced the expression of TRPV5, calbindin-D28K, and NCX1. This decline in expression of Ca2+ transporters resulted in decreased active Ca2+ reabsorption and the development of hypocalcemia . After PTH supplementation, the expression of Ca2+ transporters, as well as increased plasma Ca2+ concentration were normalized in these parathyroidectomized rats. In addition, the regulation by PTH was investigated in primary cultures of rabbit CNT cells. In these Ca2+-transporting cells, PTH resulted in an elevated expression of the Ca2+ transport proteins TRPV5, calbindin-D28K, NCX1, and PMCA1b. Taken together, these results indicate that PTH stimulates renal Ca2+ handling by co-regulating the expression of the Ca2+ transport proteins . In addition, experiments in these primary CNT cell cultures supported a gatekeeper role of TRPV5 since a blockade of the apical Ca2+ influx by ruthenium red prevented the PTH-induced upregulation of the other Ca2+ transporters.
The vitamin D endocrine system plays a pivotal role in Ca2+ homeostasis. In the recent years, it has become clear that the active form of vitamin D (1,25-dihydroxyvitamin D3, or abbreviated 1,25(OH)2D3) is a potent regulator of the Ca2+ transport proteins. Several groups have shown transcriptional regulation of TRPV5, calbindin-D28K, and NCX1 by 1,25(OH)2D3, whereas a 1,25(OH)2D3-sensitivity for PMCA1b is not consistently reported. Studies in vitamin-D-deficient knockout models showed an impressive downregulation of renal TRPV5, calbindin-D28K, and NCX1 mRNA that could be normalized by 1,25(OH)2D3 supplementation, whereas PMCA1b was not significantly affected . On the other hand, several studies indicated that PMCA1b is positively regulated by 1,25(OH)2D3 in the intestine to increase Ca2+ absorption. Northern blot analysis indicated that repletion of vitamin-D-deficient chickens with vitamin D increases PMCA mRNAs in the duodenum, jejunum, ileum, and colon . Because these studies and the role of vitamin D in Ca2+ homeostasis have been reviewed extensively [29, 64, 70], detailed information is not included in this review.
Although estrogen is generally not considered as a calciotropic hormone, it is widely accepted that it plays a role in renal Ca2+ handling. In rats, estradiol has been suggested to enhance the expression of TRPV5, NCX1, PMCA1b, and calbindin-D28K . In line with these observations, a recent study with aromatase deficient mice lacking the aromatase enzyme (aromatase−/−) and, therefore, estrogen deficient, also showed decreased expression of these transporters and concomitant renal Ca2+ wasting . Additionally, estradiol treatment of these animals normalized the urinary Ca2+ excretion and gene expression. In agreement with these observations, increased renal Ca2+ wasting, as well as renal stone formation in women after menopause, is a well-known phenomenon , suggesting that estrogens may significantly contribute to the regulation of the transepithelial Ca2+ transport in the DCT2/CNT.
Controlling the intracellular trafficking
S100A10 (also known as annexin-2 light chain) is an auxiliary protein for TRPV5 . With two Ca2+-insensitive EF-hands, S100A10 is predominantly present as a heterotetrameric complex with annexin-2, which has been implicated in many cellular processes, including endocytosis and exocytosis . An important regulatory role has been proposed for the S100A10–annexin-2 heteromer in TRPV5 functioning . The binding of annexin-2 to TRPV5 through S100A10 was shown to facilitate the translocation of TRPV5 toward the plasma membrane. This association of S100A10 and TRPV5 takes place through a short conserved peptide sequence, located in the carboxyl-terminus of TRPV5. Moreover, co-expression of S100A10, annexin-2, and TRPV5 has been observed in DCT2/CNT . Taken together, these findings show that the S100A10–annexin-2 complex is a significant component for trafficking of TRPV5 toward the plasma membrane.
The small GTPase Rab11a has also been identified as a novel TRPV5- associated protein . Rab11a is one of the key regulatory proteins that controls the recycling of endosomes [10, 76]. Rab11a was found to co-localize with TRPV5 in the DCT2/CNT. Here, both TRPV5 and Rab11a are present in subapical vesicular structures . In addition, a direct protein–protein interaction was observed between Rab11a and TRPV5, suggesting that TRPV5 channels, present on the apical plasma membrane, recycle from the intracellular (recycling) endosomes in a Rab11-dependent manner.
Clathrin and caveolin
Van de Graaf and coworkers observed that the extraction of TRPV5 from the cell surface takes place in a constitutive clathrin-dependent manner . In addition, the same authors showed that following its internalization, TRPV5 is not immediately targeted to protein degradation. Instead, by entering a Ca2+-dependent recycling pathway, TRPV5 remained stable in the subapical endosomal fraction . Another recent study by Huang et al. suggested a caveolin-1-mediated internalization of TRPV5, which was inhibited by PKC . Caveolin-1 is a structural component of caveolae and is crucial for the stabilization of the specialized membrane domains. Moreover, the caveolae-dependent internalization of TRPV5 was strongly inhibited by PTH-induced phosphorylation of TRPV5 via PKC, indicating that next to its genetic effect on expression, PTH also has a rapid effect on channel abundance . These findings indicate that apical sorting of TRPV5 is likely to be mediated by several mechanisms that could be differentially controlled depending on physiological needs of the body.
Regulation of TRPV5 activity at the membrane
Intracellular Ca2+, Mg2+, and PIP2
Although the Ca2+ concentration in the luminal compartment of DCT2/CNT is in the 1.0–1.5 mM range, the resting [Ca2+]i in these cells is maintained around 100 nM by NCX1 and PMCA1b. TRPV5 has a high Ca2+ selectivity, and at physiological Ca2+ concentrations, its current is mainly carried by Ca2+. In human embryonic kidney (HEK293) cells heterogeneously expressing TRPV5, currents can be activated under conditions of high intracellular Ca2+ buffering by hyperpolarizing voltage steps. Earlier, Nilius et al. suggested that intracellular Ca2+ acts as a negative feedback switch regulating TRPV5 activity. The Ca2+ current through TRPV5 is inhibited by the [Ca2+]i with an IC50 of 82 nM . Considering this high affinity of Ca2+-dependent channel inhibition, the presence of the co-expressed Ca2+ buffer calbindin in DCT2/CNT plays an important role to maintain TRPV5 activity. Conclusively, the [Ca2+]i itself directly regulates channel function in order to maintain optimal Ca2+ reabsorption without excessive influx of Ca2+.
Single TRPV5 channel currents in cell-attached and inside-out patches were only detected in the absence of Ca2+ and had a conductance of ∼75 pS . So far, no reliable single channel measurements have been performed in the presence of extracellular Ca2+. Another interesting feature of TRPV5 is the open pore blockage by intracellular Mg2+. Currents through TRPV5 are small at physiological extracellular Mg2+ and Ca2+ concentrations, but sufficient to increase the [Ca2+]i at hyperpolarized potentials. Therefore, block by Mg2+ and decrease of the current by extracellular Ca2+ might be physiologically important to prevent Ca2+ overload of TRPV5-expressing cells [51, 75]. In addition, Huang and colleagues reported that PIP2 activates TRPV5 and that activation of the channel by PIP2 reduces the sensitivity of TRPV5 to the inhibition by the intracellular [Mg2+] [17, 42]. In this model, hydrolysis of PIP2 by receptor activation of PLC may increase the sensitivity for Mg2+ inhibition.
Another protein called 80K-H has been shown to directly interact with TRPV5 in a Ca2+-dependent manner . The 80K-H protein contains two putative EF-hands and an ER-targeting signal. This TRPV5-linked protein was originally cloned as a PKC substrate and was subsequently associated with intracellular signaling . Binding with Ca2+ abolished the inactivation of the two EF-hand motifs of 80K-H, and this, in turn, reduced the TRPV5-mediated Ca2+ current and increased the sensitivity of TRPV5 to the [Ca2+]i, accelerating the feedback inhibition of the channel . Moreover, 80K-H also co-localizes with TRPV5 in the DCT2/CNT. Based on these findings, 80K-H has been hypothesized to act a Ca2+ sensor to regulate the activity of TRPV5 at the plasma membrane .
Pro-urinary factors stabilize TRPV5 in the apical membrane
Tissue kallikrein (TK) is a multifunctional serine protease that is primarily synthesized in the DCT2 and CNT and catalyzes the kininogen kinin conversion . TK is secreted into the pro-urine, where it mediates the formation of bradykinin that binds to the type 2 bradykinin receptor (B2R) . A striking effect of TK has been observed in primary rabbit CNT cells mediating transcellular Ca2+ transport . Apical addition of TK or bradykinin (BK) significantly increased transcellular Ca2+ transport that was prevented by B2R antagonists, whereas basolateral application of either TK or BK had no effect . This stimulatory effect of TK was mediated by the apical B2R signaling through the phospholipase C/diacylglycerol/PKC pathway, resulting in phosphorylation of TRPV5 and subsequent delay in its retrieval from the plasma membrane. Additionally, mice lacking TK (TK−/−) waste a large amount of Ca2+ without any significant alterations in plasma Ca2+, PTH, and vitamin D3 levels or any detectable changes in the expression of Ca2+ transporters in the DCT2/CNT. These observations together highlight the importance of the regulation of the TRPV5 channel abundance in the membrane by the pro-urine TK.
Urinary pH and Mg2+
The acid–base balance has long been known to affect Ca2+ homeostasis. For example, patients with chronic metabolic acidosis waste Ca2+. Pioneering micropuncture studies have shown that chronic metabolic acidosis results in Ca2+ wasting . Recent advances in total reflection fluorescent microscopy analysis allowed the identification of the molecular basis underlying these in vivo observations. Exposure of TRPV5-expressing cells to an alkaline extracellular environment (pH 8.0) caused rapid recruitment of TRPV5-containing vesicles to the cell surface and a consequent increase in TRPV5 activity . In the reciprocal experiment, acidic extracellular milieu (pH 6.5) induced the internalization of TRPV5-containing vesicles from the plasma membrane, resulting in a reduced channel activity . The extracellular acidity clearly affected the current kinetics resulting in diminished single channel conductance as shown by Yeh et al. . Binding of protons to an extracellular glutamate near the pore helix of TRPV5 at position 522 (E522) resulted in decreased channel activity, whereas substitution with a glutamine (E522→Q522) abolished the proton sensitivity. This recognized E522 as the extracellular pH sensor in TRPV5. Based on these experiments, binding of protons to the sensor has been proposed to induce a conformational change of the TRPV5 pore helix, leading to a lowered channel activity. These observations clearly point out that urinary acidification results in decreased channel activity at the apical cell membrane, as well as in a rapid retrieval of TRPV5 from the apical membrane, both of which are likely to account for the renal Ca2+ wasting in metabolic acidosis. Also, urinary Mg2+ is known to modulate urinary Ca2+ excretion, but the mechanism underlying this relationship is unknown. In a recent study by Bonny et al., it was elegantly demonstrated that an alteration in urinary Ca2+ excretion is directly proportional to the change in Mg2+ excretion and inversely proportional to the adjustment in urine pH . Because TRPV5 was inhibited by Mg2+, these data are compatible with the hypothesis that urinary Mg2+ directly inhibits Ca2+ reabsorption in DCT2/CNT, which can be overruled by an alkaline luminal pH.
Klotho is a type-I (single-pass) membrane protein predominantly expressed in tissues involved in Ca2+ homeostasis, such as kidney, choroid plexus, and the parathyroid gland . The ablation of klotho causes severe multiple phenotypes in klotho-deficient (klotho−/−) mice, such as short life span associated with infertility and sternly impaired Ca2+ and phosphate metabolism [38, 65]. There is a growing body of evidence that klotho controls active Ca2+ reabsorption in the DCT2/CNT segments through several mechanisms.
In kidney, klotho is exclusively expressed in DCT2/CNT, where following extracellular domain shedding, it is secreted into the circulation and the pro-urine . The secreted form of klotho exerts β-glucuronidase activity . More importantly, klotho was suggested to regulate the apical entry of Ca2+ in the DCT2/CNT region. The presence of extracellular klotho robustly increased the activity of TRPV5 in cultured rabbit primary CNT cells. Moreover, TRPV5-expressing HEK293 cells also showed a significant rise in channel activity after klotho treatment that was accompanied with concomitant increased plasma membrane channel abundance . In addition, removal of the complete N-glycan tree by Endo-F was recently reported to result in a more pronounced increase in TRPV5 activity compared to that of observed upon klotho treatment . Recently, Cha et al. suggested sialidase rather than β-glucuronidase activity for klotho, as they observed a klotho-mediated removal of terminal sialic acids from the N-glycan in TRPV5 . This cleavage exposed the underlying galactose-N-acetylglucoseamine disaccharides in TRPV5, which can directly interact with membrane-bound galectin-1, causing the subsequent plasma membrane retention of TRPV5. Interestingly, treatment with PNGaseF to hydrolyze the entire N-glycan of TRPV5 mimicked the stimulatory effect of klotho, suggesting additional mechanisms besides binding to membrane galectin-1. It should be noted that Cha et al. also reported a comparable increase in TRPV5 activity upon β-glucuronidase treatment; however, this effect could be observed only at much higher (0.1–1 μM) concentrations of the enzyme, suggesting that klotho exhibits primarily sialidase activity at physiologic concentrations (∼20–200 pM) . These observations confirmed the original conclusion that extracellular klotho hydrolyses oligosaccharide chains from the N-glycosylated TRPV5, causing channel retention at the membrane and a subsequent increase in TRPV5-mediated Ca2+ influx . In line with these findings, microperfusion studies have shown that CNTs from klotho−/− mice fail to respond to PTH and, therefore, waste large amount of Ca2+ . Interestingly, klotho was reported to interact and increase Na+/K+-ATPase activity at the plasma membrane and stimulating the Na+/Ca2+ exchange through NCX1 . Taken altogether, there is compelling evidence that klotho is a novel calciotropic factor that, amongst others, can exert its stimulatory effect on TRPV5 cell surface retention from the pro-urine in the DCT2 and the CNT.
Several clinical disorders, such as chronic renal failure or diabetes, are associated with the symptoms of dysregulating body Ca2+ homeostasis. Chronic renal failure (CRF) is frequently characterized by hypocalcemia, osteoporosis, growth retardation, and secondary hyperparathyroidism. Remarkably, the phenotype of the klotho−/− mice resembles most of these characteristics . Moreover, CRF patients also have greatly reduced renal klotho levels . Together with the fact that klotho can regulate the activity of TRPV5 and NCX1 via Na+/K+-ATPase, the involvement of klotho in the pathogenesis of Ca2+ abnormalities in CRF may be envisaged.
Hypercalciuria and nephrolithias, disorders with a high prevalence and socio–economic burden in the Western society, are often treated with thiazide diuretics. These drugs are known to affect the Ca2+ balance by inducing hypocalciuria. Over the last decade, it was speculated that thiazide-inhibited NCC activity stimulates active Ca2+ reabsorption in the DCT/CNT. However, recent studies indicated that paracellular Ca2+ transport in the proximal tubule due to extracellular volume contraction explains the hypocalciuria during chronic thiazide treatment [48, 49]. Hypercalciuria is also an early finding in diabetes mellitus patients. Similarly, rats with experimentally induced diabetes display a significant increase in the fractional excretion of Ca2+ . However, these diabetic rats showed increased mRNA and protein levels of both TRPV5 and calbindin-D28K. Additionally, insulin therapy corrected the hyperglycemia-associated hypercalciuria and abolished the upregulation of TRPV5, suggesting that the increased TRPV5 abundance in diabetic rats is due to a compensatory adaptation to an increased load of Ca2+ secondary to hyperglycemia. Although in many pathophysiological conditions the expression level of the Ca2+ transporters is out of balance, mutations in these proteins have not been discovered yet.
Concluding remarks and future perspectives
Ca2+ reabsorption in the kidney and particularly in the distal DCT2/CNT segments of the nephron is critical in the maintenance of the Ca2+ balance. Here, TRPV5 is the gatekeeper of the Ca2+ entry, and therefore, a tight control of its activity enables the organism to adjust Ca2+ reabsorption according to any demands of the body. The available experimental data summarized in this review highlights the most important mechanisms that can actually regulate active Ca2+ reabsorption. Of these, controlling the TRPV5 cell surface expression by extracellular factors in the pro-urine is a newly discovered mechanism. Klotho delays the retrieval of TRPV5 from the cell membrane by modifying the N-glycan composition, whereas the insertion of channels in the cell membrane is promoted by TK-induced phosphorylation or alkaline pH. All mechanisms result in increased TRPV5 abundance and, in turn, regulate the entry of Ca2+ at the gate. However, the canvas is far from complete. The molecular mechanism by which intracellular Ca2+ bound to calbindin-D28K is transported to the basolateral extrusion transporters NCX1 and PMCA1b is largely unknown. It could be envisaged that the local Na+ concentration may promote the release of Ca2+; however, no experimental data are available to support this theory. Therefore, the Ca2+ transfer between calbindin-D28K on one site and NCX1 and PMCA1b on the other site needs special attention. Another interesting question to be solved is the regulation of the basolateral trafficking of NCX1 and PMCA1b in the DCT2 and CNT cells. Certain players, such as the scaffold 14-3-3, phospholemman, ankyrin, or caveolin-3, have been proposed to play a role in the trafficking of the NCX transporters in neurons and cardiac cells. Nevertheless, the basolateral sorting of these transporters in the DCT2/CNT is essentially unknown. Whether there is a crosstalk between the apical Ca2+ entry and the basolateral Ca2+ extrusion regulatory apparatus is not known. The fact that klotho increases both the channel abundance of TRPV5 in the apical membrane and the activity of NCX1 at the basolateral side certainly predicts the existence of such crosstalk [14, 34]. The main question for the coming years is how all of these Ca2+ transport proteins communicate with each other in order to facilitate optimal and regulated transcellular Ca2+ reabsorption in DCT2 and CNT under conditions of disturbed Ca2+ homeostasis.
This work was financially supported in part by grants from the Dutch Kidney Foundation (C03.6017, C06.2170), the Netherlands Organization for Scientific Research (NWO-ALW 814.02.001, NWO-CW 700.55.302, ZonMw 9120.6110). J. Hoenderop is supported by an EURYI award.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
- 1.Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA (2007) Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res 22:274–285PubMedCrossRefGoogle Scholar
- 34.Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, Obuse C, Togashi K, Tominaga M, Kita N, Tomiyama K, Iijima J, Nabeshima Y, Fujioka M, Asato R, Tanaka S, Kojima K, Ito J, Nozaki K, Hashimoto N, Ito T, Nishio T, Uchiyama T, Fujimori T, Nabeshima Y (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316:1615–1618PubMedCrossRefGoogle Scholar
- 59.Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885–3894PubMedCrossRefGoogle Scholar